-+ 0.00%
-+ 0.00%
-+ 0.00%
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The group has obtained approval from the China National Drug Administration for drug production registration for norepinephrine bitartrate injection (1ml: 2mg). It is a category 3 chemical drug. It is considered to have passed the consistency evaluation and is mainly used for blood pressure control in certain acute hypotensive states.
Share
Listen to the news
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The group has obtained approval from the China National Drug Administration for drug production registration for norepinephrine bitartrate injection (1ml: 2mg). It is a category 3 chemical drug. It is considered to have passed the consistency evaluation and is mainly used for blood pressure control in certain acute hypotensive states.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending